Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Free access | 10.1172/JCI110072

Influence of the Vitamin D-binding Protein on the Serum Concentration of 1,25-Dihydroxyvitamin D3: SIGNIFICANCE OF THE FREE 1,25-DIHYDROXYVITAMIN D3 CONCENTRATION

Roger Bouillon, Frans A. Van Assche, Hugo Van Baelen, Walter Heyns, and Pieter De Moor

Laboratorium voor Experimentele Geneeskunde and Department of Obstetrics, Rega Instituut, Katholieke Universiteit Leuven, Leuven, Belgium

Find articles by Bouillon, R. in: PubMed | Google Scholar

Laboratorium voor Experimentele Geneeskunde and Department of Obstetrics, Rega Instituut, Katholieke Universiteit Leuven, Leuven, Belgium

Find articles by Van Assche, F. in: PubMed | Google Scholar

Laboratorium voor Experimentele Geneeskunde and Department of Obstetrics, Rega Instituut, Katholieke Universiteit Leuven, Leuven, Belgium

Find articles by Van Baelen, H. in: PubMed | Google Scholar

Laboratorium voor Experimentele Geneeskunde and Department of Obstetrics, Rega Instituut, Katholieke Universiteit Leuven, Leuven, Belgium

Find articles by Heyns, W. in: PubMed | Google Scholar

Laboratorium voor Experimentele Geneeskunde and Department of Obstetrics, Rega Instituut, Katholieke Universiteit Leuven, Leuven, Belgium

Find articles by De Moor, P. in: PubMed | Google Scholar

Published March 1, 1981 - More info

Published in Volume 67, Issue 3 on March 1, 1981
J Clin Invest. 1981;67(3):589–596. https://doi.org/10.1172/JCI110072.
© 1981 The American Society for Clinical Investigation
Published March 1, 1981 - Version history
View PDF
Abstract

The influence of the serum binding protein (DBP) for vitamin D and its metabolites on the concentration of its main ligands, 25-hydroxyvitamin D3 (25-OHD3) and 1,25-dihydroxyvitamin D3 (1,25-[OH]2D3) was studied. The concentration of both 1,25-(OH)2D3 and DBP in normal female subjects (45±14 ng/liter and 333±58 mg/liter, mean±SD, respectively; n = 58) increased during the intake of estro-progestogens (69±27 ng/liter and 488±90 mg/liter, respectively; n = 29), whereas the 25-OHD3 concentration remained unchanged. A positive correlation was found between the concentrations of 1,25-(OH)2D3 and DBP in these women.

At the end of pregnancy, the total concentrations of 1,25-(OH)2D3 (97±26 ng/liter, n = 40) and DBP (616±84 mg/liter) are both significantly higher than in nonpregnant females and paired cord serum samples (48±11 ng/liter and 266±41 mg/liter, respectively). A marked seasonal variation of 25-OHD3 was observed in pregnant females and their infants, whereas in the same samples the concentrations of both DBP and 1,25-(OH)2D3 remained constant throughout the year.

The free 1,25-(OH)2D3 index, calculated as the molar ratio of this steroid and DBP, remains normal in women taking estro-progestogens, however, and this might explain their normal intestinal calcium absorption despite a high total 1,25-(OH)2D3 concentration. In pregnancy the free 1,25-(OH)2D3 index remains normal up to 35 wk of gestation, but during the last weeks of gestation, the free 1,25-(OH)2D3 index increases in both circulations. A highly significant correlation exists between the (total and free) 25-OHD3 and 1,25-(OH)2D3 concentrations in maternal and cord serum both at 35 and 40 wk of gestation.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 589
page 589
icon of scanned page 590
page 590
icon of scanned page 591
page 591
icon of scanned page 592
page 592
icon of scanned page 593
page 593
icon of scanned page 594
page 594
icon of scanned page 595
page 595
icon of scanned page 596
page 596
Version history
  • Version 1 (March 1, 1981): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts